6505--Metolazone Tablets (VA-26-00032237)

The Department of Veterans Affairs National Acquisition Center is soliciting offers for the procurement of Metolazone Tablets in three strengths: 2.5mg, 5mg, and 10mg, with annual quantities of 7,649, 6,614, and 700 bottles respectively, each containing 100 tablets per bottle. All offerors must meet FDA current Good Manufacturing Practice (cGMP) standards, identify FDA-inspected manufacturing facilities, and provide unique 11-digit National Drug Code (NDC) numbers for each offered product strength. The solicitation requires offerors to acknowledge receipt of two amendments issued on April 14 and April 22, 2026, with the final deadline for proposal submission set for April 22, 2026, at 2:30 PM Central Daylight Time. Award will be made to the lowest price technically acceptable offer that meets all product specifications and FDA requirements, with pricing to include a 0.5% Cost Recovery Fee. Non-small business offerors exceeding $900,000 in contract value must submit an approved subcontracting plan with minimum goals for service-disabled veteran-owned and veteran-owned small business participation.

This procurement is not designated with any small business set-asides and will result in a single award on an aggregate basis covering a base year plus four optional one-year extension periods, with implementation not to exceed 60 days. Products will be distributed through the VA and DoD Pharmaceutical Prime Vendor Programs to multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, and the Captain James A. Lovell Federal Health Care Center. The solicitation requires specific packaging compliance including bar coding in GS1-128 or HIBCC format, Drug Supply Chain Security Act (DSCSA) serialization requirements, and compatibility with automated dispensing units. Contractors must maintain the same manufacturer throughout the contract duration unless the Contracting Officer approves changes, and must report any FDA violations, Form FDA 483 notices, or Warning Letters within 15 calendar days. The place of performance is through the VA National Acquisition Center in Hines, Illinois, with proposals to be submitted via email to the designated VA contracting officers.